Abstract
10B‐Enriched borocaptate (BSH) was administered intraperitoneally to SCCVII tumor‐bearing C3H/He mice. Electroporation (EP) was conducted by using a tweezers‐type electrode. The 10B contents in tumors were measured by prompt γ‐ray spectrometry. The colony formation assay was applied to investigate the antitumor effects of boron neutron capture therapy (BNCT) and thereby to estimate the intratumor localization of BSH. The 10B concentrations in tumors decreased with time following BSH administration, falling to 5.4(±0.1) ppm at 3 h, whereas EP treatment (3 repetitions) 15 min after BSH injection delayed the clearance of BSH from tumors, and the 10B level remained at 19.4(±0.9) ppm at 3 h. The effect of BNCT increased with the 10B concentration in tumors, and the combination with EP showed a remarkably large cell killing effect even at 3 h after BSH injection. The effect of BNCT, i.e., slope coefficient of the cell survival curve of tumors, without EP was proportional to tumor 10B level (r=0.982), and that of BSH‐BNCT combined with EP lay close to the same correlation line. However, tumors subjected to EP after BSH injection did not show high radiosensitivity when irradiated after conversion to a single cell suspension by enzymatic digestion. This indicates that the increase of the BNCT effect by EP was a consequence of enclosure of BSH in the interstitial space of tumor tissue and not within tumor cells. This is different from a previous in vitro study. The combination of EP and BNCT may be clinically useful, if a procedure to limit EP to the tumor region becomes available or if an alternative similar method is employed.
Keywords: BSH, Electroporation, SCCVII tumors
Full Text
The Full Text of this article is available as a PDF (68.8 KB).
REFERENCES
- 1. ) Barth , R. F. , Soloway , A. H. and Fairchild , R. G.Boron neutron capture therapy of cancer . Cancer Res. , 50 , 1061 – 1070 ( 1990. ). [PubMed] [Google Scholar]
- 2. ) Wazer , D. E. , Zamenhof , R. G. , Harling , O. K. and Madoc‐Jones , H.Boron neutron capture therapy . In“Radiation Oncology Technology and Biology ,” ed. March P. M. and Loeffler J. S. , pp. 167 – 191 ( 1994. ). W. B. Saunders; , Philadelphia . [Google Scholar]
- 3. ) Hatanaka , H.Boron neutron capture therapy for tumors . In“Glioma ,” ed. Karim A. B. M. F. and Law E. R. , pp. 233 – 249 ( 1991. ). Springer‐Verlag; , Berlin and Heidelberg . [Google Scholar]
- 4. ) Zimmermann , U. , Vienken , J. and Pilwat , G.Development of drug carrier systems: electric field induced effects in cell membranes . J. Electroanal. Chem. , 116 , 553 – 574 ( 1980. ). [Google Scholar]
- 5. ) Ono , K. , Kinashi , Y. , Masunaga , S. , Suzuki , M. and Takagaki , M.Electroporation increases the effect of 10B‐BSH (borocaptate) in neutron capture therapy . Int. J. Radiat. Oncol. Biol Phys. , 42 , 823 – 826 ( 1998. ). [DOI] [PubMed] [Google Scholar]
- 6. ) Ono , K. , Kinashi , Y. , Masunaga , S. , Suzuki , M. and Takagaki , M.Effect of electroporation on cell killing by boron neutron capture therapy using borocaptate sodium (10B‐BSH) . Jpn. J. Cancer Res. , 89 , 1352 – 1357 ( 1998. ). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. ) Ono , K. , Masunaga , S. , Kinashi , Y. , Takagaki , M. , Akaboshi , M. , Kobayashi , T. and Akuta , K.Radiobiological evidence suggesting heterogeneous microdistribution of boron compounds in tumors: its relation to quiescent cell population and tumor cure in neutron capture therapy . Int. J. Radiat. Oncol. Biol. Phys. , 34 , 1081 – 1086 ( 1996. ). [DOI] [PubMed] [Google Scholar]
- 8. ) Hatanaka , H.Introduction . In“Boron‐neutron Capture Therapy for Tumors ,” ed. Hatanaka H. , pp. 1 – 28 ( 1986. ). Nishimura Co. , Niigata . [Google Scholar]
- 9. ) Stragliotto , G. and Fankhauser , H.Biodistribution of boron sulfhydryl for boron neutron capture therapy in patients with intracranial tumors . Neurosurgery , 36 , 285 – 293 ( 1995. ). [DOI] [PubMed] [Google Scholar]
- 10. ) Haselsberger , K. , Radner , H. and Pendl , G.Boron neutron capture therapy: boron biodistribution and pharmacokinetics of Na2B12H11SH in patients with glioblastoma . Cancer Res. , 54 , 6318 – 6320 ( 1994. ). [PubMed] [Google Scholar]
- 11. ) Takagaki , M. , Oda , Y. , Miyatake , S. , Kikuchi , H. , Osawa , M. , Ono , K. and Mori , K.Boron neutron capture therapy — preliminary study of BNCT with sodium borocaptate (Na2B12H11SH) on glioblastoma . J. Neurooncol. , 35 , 177 – 185 ( 1997. ). [DOI] [PubMed] [Google Scholar]
- 12. ) Fairchild , R. G. , Kahl , S. B. , Laster , B. H. , Kalef‐Ezra , J. and Popenoe , E. A.In vitro determination of uptake, retention, distribution, biological efficacy, and toxicity of boronated compounds for neutron capture therapy: a comparison of porphyrins with sulfhydryl boron hydrides . Cancer Res. , 50 , 4860 – 4865 ( 1990. ). [PubMed] [Google Scholar]
- 13. ) Ceberg , C. P. , Brun , A. , Mir , L. M. , Persson , B. R. R. and Salford , L. G.Enhanced boron uptake in RG 2 rat glioma by electropermealization In vivo—a new possibility in boron neutron capture therapy . Anticancer Drugs , 5 , 463 – 466 ( 1994. ). [DOI] [PubMed] [Google Scholar]
- 14. ) Kambe , M. , Ioritani , N. , Shirai , S. , Kambe , K. , Kuwahara , M. , Arita , D. , Funato , T. , Shimodaira , H. , Gamo , M. , Orikasa , S. and Kanemaru , R.Enhancement of chemotherapeutic effects with focused shock wave: extracorporeal shock wave chemotherapy (ESWC) . In Vivo , 10 , 369 – 376 ( 1996. ). [PubMed] [Google Scholar]
- 15. ) Kambe , M. , Arita , D. , Kikuchi , H. , Funato , T. , Tezuka , F. , Gamo , M. , Murakawa , Y. and Kanemaru , R.Enhancement of the efficiency of anticancer drugs with electroporation: successful electrochemotherapy against gastric cancer cell line in vivo and in vitro . Int. J. Clin. Oncol. , 2 , 111 – 117 ( 1997. ). [Google Scholar]